The European Securities and Markets Authority (ESMA) has published a statement concerning significant benchmarks that have been notified by CME under Article 24(2) of the EU Benchmark Regulation (BMR). The document, identified by reference ESMA81-1841807023-1069, serves to provide clarity on these specific notifications within the European financial market.

This statement is primarily informational and does not appear to impose new obligations or deadlines on regulated entities. Compliance officers should note this clarification for their understanding of benchmark oversight within the EU framework, particularly concerning entities that rely on or are impacted by benchmarks managed by CME. No immediate action is required based on this notice.